Latest Insider Transactions at Oak Street Health, Inc. (OSH)
This section provides a real-time view of insider transactions for Oak Street Health, Inc. (OSH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oak Street Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oak Street Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
86,017
-1.62%
|
$3,440,680
$40.3 P/Share
|
|
Nov 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
23,383
-0.44%
|
$935,320
$40.0 P/Share
|
|
Nov 09
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
28,100
-0.2%
|
$1,124,000
$40.56 P/Share
|
|
Nov 04
2021
|
Julie D Klapstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+21.38%
|
-
|
|
Nov 04
2021
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+34.73%
|
-
|
|
Nov 04
2021
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+2.18%
|
-
|
|
Nov 04
2021
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+5.3%
|
-
|
|
Nov 04
2021
|
Cheryl Dorsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+24.14%
|
-
|
|
Nov 04
2021
|
Paul B. K. Kusserow Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+0.94%
|
-
|
|
Nov 04
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.43%
|
$271,492
$46.1 P/Share
|
|
Nov 02
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.17%
|
$2,300,000
$46.55 P/Share
|
|
Oct 28
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.58%
|
$690,000
$46.53 P/Share
|
|
Oct 26
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
72,500
-1.46%
|
$3,262,500
$45.65 P/Share
|
|
Oct 21
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,328
-0.55%
|
$464,760
$45.52 P/Share
|
|
Oct 19
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.33%
|
$2,100,000
$42.03 P/Share
|
|
Oct 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-1.0%
|
$4,485,400
$41.99 P/Share
|
|
Oct 12
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.37%
|
$1,017,500
$37.2 P/Share
|
|
Oct 07
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,476
-0.16%
|
$60,516
$41.42 P/Share
|
|
Oct 05
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.33%
|
$2,050,000
$42.0 P/Share
|
|
Sep 28
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.96%
|
$2,300,000
$46.13 P/Share
|
|
Sep 23
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.2%
|
$295,100
$50.19 P/Share
|
|
Sep 21
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.33%
|
$2,500,000
$50.62 P/Share
|
|
Sep 16
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.57%
|
$780,000
$52.13 P/Share
|
|
Sep 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.99%
|
$5,688,800
$52.13 P/Share
|
|
Sep 14
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.64%
|
$2,600,000
$52.78 P/Share
|
|
Sep 09
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.4%
|
$306,904
$52.23 P/Share
|
|
Sep 07
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.22%
|
$2,550,000
$51.61 P/Share
|
|
Sep 02
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,434
-0.41%
|
$260,832
$48.88 P/Share
|
|
Aug 31
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.32%
|
$2,300,000
$46.12 P/Share
|
|
Aug 26
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.3%
|
$277,394
$47.36 P/Share
|
|
Aug 24
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.88%
|
$2,350,000
$47.61 P/Share
|
|
Aug 19
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,566
-0.36%
|
$430,470
$45.79 P/Share
|
|
Aug 17
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.32%
|
$2,300,000
$46.79 P/Share
|
|
Aug 16
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.49%
|
$5,251,200
$48.88 P/Share
|
|
Aug 12
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.3%
|
$301,002
$51.14 P/Share
|
|
Aug 10
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.47%
|
$2,650,000
$53.42 P/Share
|
|
Aug 05
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
7,893
-0.29%
|
$513,045
$65.12 P/Share
|
|
Aug 03
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.32%
|
$3,200,000
$64.14 P/Share
|
|
Jul 29
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.58%
|
$365,924
$62.89 P/Share
|
|
Jul 28
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
66,358
-0.42%
|
$4,047,838
$61.91 P/Share
|
|
Jul 27
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.91%
|
$2,950,000
$59.74 P/Share
|
|
Jul 23
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,169
-0.19%
|
$925,309
$61.11 P/Share
|
|
Jul 22
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
22,500
-0.55%
|
$1,350,000
$60.86 P/Share
|
|
Jul 22
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,473
-0.04%
|
$211,853
$61.02 P/Share
|
|
Jul 20
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
185,000
-0.58%
|
$10,545,000
$57.56 P/Share
|
|
Jul 15
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.19%
|
$324,610
$55.63 P/Share
|
|
Jul 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-0.63%
|
$6,017,000
$55.55 P/Share
|
|
Jul 13
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.89%
|
$2,850,000
$57.99 P/Share
|
|
Jul 01
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.29%
|
$342,316
$58.49 P/Share
|
|
Jul 01
2021
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.83%
|
$580,000
$58.51 P/Share
|